• Info
  • Significant Ownership

Significant Ownership of Versant Venture Capital V, L.P.

Signature - Title
/s/ Max Eisenberg - Max Eisenberg, COO of Versant Ventures V, LLC the GP of Versant Venture Capital V, L.P.
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Versant Venture Capital V, L.P..

Notify me when Versant Venture Capital V, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Versant Venture Capital V, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TSBX Turnstone Biologics Corp. Common Stock, $0.001 par value per share 0% $0 0 Versant Venture Capital V, L.P. Aug 8, 2025
RPTX Repare Therapeutics Inc. Common Shares 0% $0 0 Versant Venture Capital V, L.P. Nov 19, 2025

Schedules 13D/G Reported by Versant Venture Capital V, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.